why do glp 1 agonists cause nausea Outpatient Sedation Basics for Patients on GLP-1 Medications GLP-1 Causing Nausea: Navigating Side
Description
It represented a genuine milestone: the first oral GLP-1 receptor agonist to reach the market
10.4103/2230-8210.85583 77 HavaleS
Key Pharmacokinetic Parameters The table below describes the key pharmacokinetic parameters for DPP-4 inhibitors: Cautions and contraindications Cautions and contraindications for the use of DPP-4 inhibitors are listed below: Adverse effects Other adverse effects include: Increased risk of infection with saxagliptin, alogliptin and vildagliptin Hypersensitivity reactions (including anaphylaxis, angioedema, stevens-johnson syndrome) Sitagliptin: interstitial lung disease, impaired renal function, thrombocytopenia, and acute renal failure
Second-generation oral semaglutide, whose bioavailability and safety have been significantly improved by the application of new excipients and formulation optimization, but its gastrointestinal side effects are still obvious (Nielsen et al., 2025)
1, Middle panel)
Unlike GLP-1 agonists, DPP-4 inhibitors do not affect satiety, gastric emptying, or induce weight loss
